Skip to main content
Hit enter to search or ESC to close
Close Search
USAUSA
Menu
  • USA
    • UK
    • EU
    • Rest of the World
  • Menu
Category

Diabetic Screening

On a mission to democratize eyecare, Toku Eyes takes its technology to the U.S.
AI TechnologyDiabetic ScreeningEye Health

On a mission to democratize eyecare, Toku Eyes takes its technology to the U.S.

NZ-based AI firm launches tool to assess heart risk through retinal scans in U.S.
AI TechnologyDiabetic ScreeningEye Health

NZ-based AI firm launches tool to assess heart risk through retinal scans in U.S.

Diabetic ScreeningEye Health

New Zealand tech company develops tool to detect diseases like diabetes

A multi-center prospective evaluation of THEIA
AI TechnologyBusiness NewsDiabetic Screening

A multi-center prospective evaluation of THEIA

Recent Posts

  • The eye exam detecting chronic health conditions
  • Toku Appoints Former Google Head of Cardiovascular Health as Chief Health Officer
  • Toku obtains CE and UKCA marks for AI cardiovascular risk assessments through the eye
  • Toku joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
  • Toku Eyes poised for US breakthrough after big industry names back $13m raise

Categories

  • AI Technology
  • Business News
  • Clinical Trials
  • Diabetic Screening
  • Eye Health

Toku AI

Toku develops tools using AI and retinal photography to enable accessible healthcare for early and accurate diagnosis of health conditions.

Our AI Platforms

BioAge
CLAiR

Links

Our Research
Our Team
News & Media
Contact Us
Privacy Policy


Toku is a Member of the American Heart Association’s Innovators’ Network

If you’ve discovered a potential vulnerability, please contact our cybersecurity team at security@tokueyes.com
© Toku Eyes 2025 | All rights reserved | website by publiceye creative

Close Menu
  • USA
    • UK
    • EU
    • Rest of the World
  • Our AI Platforms
    • BioAge
    • CLAiR
  • Our Team
  • Our Research
  • News & Media
  • For Optometrists
  • Contact Us
  • Accessibility
    • Normal
    • Large
    • X-Large